$IXC - INVEX THERAPEUTICS - New ASX listing

Invex Therapeutics aims to re-purpose a diabetic drug for brain disorders such as idiopathic intracranial hypertension, traumatic brain injury and acute stroke.

It only just listed but seems to be headed the right way price wise. It is already up another 16% today with 99 buyers for 659,825 units vs 30 sellers for 233,020 units. Pity I didn't see it sooner.

Looks good on the 15 min chart. Might be worth a watch.

Invex Therapeutics Ltd (IXC) is a biopharmaceutical company, focused on the research and development of Exenatide as an efficacious treatment for neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke, hydrocephalus, venous sinus thrombosis, brain tumours, meningitis, secondary pseudo tumour cerebri and traumatic brain injury.

Комментарий:

Stock hasnt done much. It is at an interesting breakout area again. Could be worth a look if it shows signs of strength above 83

Комментарий:

Could be worth another look. Its up 107% over the last 3 months and has had a bit of a pullback for resuming direction.